ABSTRACT SUBMISSION
Scroll down below for Late Breaking Abstracts
The organizers invite scientists, clinicians, and researchers to submit their abstract(s) for the 14th DASIL World Congress.
ABSTRACT SUBMISSION DEADLINE:
JULY 15, 2026
ABSTRACT EVALUATION:
JULY 30, 2026
Please make sure to be fully familiar with the abstract formalities, terms & conditions before sending your abstract. Incomplete abstracts or abstracts with formal errors will not be considered!
General
The following is a directive from the IADVL and applies to all international congresses being held in India.
Please note that according to the Indian Regulations Governing Procedural Dermatology Training and Congress Participation only Dermatologists and Plastic Surgeons (and their residents) are permitted to attend this years’ DASIL World Congress in India.
-
Abstracts must contain work that has not been previously submitted and/or presented at any national or international meeting before DASIL 2026!
-
The abstract submission deadline is May 31, 2026; the abstract evaluation deadline is June 22, 2026. Authors will be notified of the abstract evaluation results by email. Abstracts submitted after May 31, 2026, will not be accepted.
-
The authors should specify if they prefer their submission to be considered for oral presentation or e-Poster.
-
The presenting author must register as a participant for the full congress.
Abstract Formalities
IMPORTANT INFORMATION
Incomplete abstracts or abstracts with formal errors will generally lead to the exclusion of abstracts!
Abstracts must be submitted as MS-Word or (editable) pdf document.
Abstracts must be submitted in English and must not exceed 300 words.
The abstract must clearly indicate the following (to be excluded from the word count):
-
Abstract title
-
Name(s) of author(s)
-
Affiliation of author(s)
-
Country of residence of author(s)
-
Current headshot for publication
The authors’ conclusion(s) should be clearly stated. General statements such as the significance of these findings will be considered unfavorably and will generally lead to the exclusion of abstracts.
Initials and abbreviations which are not in common use should be avoided unless they are essential.
Remember to check spelling and grammar carefully. Your electronically submitted abstract text will be reproduced as submitted.
Speaker Disclosure of Potential Conflicts of Interest
The DASIL Society requires that all presentations must be as bias free of commercials.
It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabled or research-associated commercial products should disclose this situation to session attendees.
Abstract Submission
Authors may submit their abstract(s) via email to
batu_gezer(at)logi-vent.deOnly electronically submitted abstracts will be considered.
Abstract Evaluation
The DASIL Scientific Board will review all abstracts without knowledge of the author’s name. Acceptance or rejection of an abstract will be based on the average grade awarded by the review committee.
The abstract should be presented in a way that the contribution of the research to advance knowledge can be assessed.
The Scientific Board reserves the right to:
-
Select the abstracts relevant to the sessions
-
Decide on the final topic of the abstract
By submitting an abstract for the 14th DASIL World Congress, the author confirms that he/she has read and understood the terms & conditions and accepts them.
LATE BREAKING ABSTRACT SUBMISSION
Notification of acceptance or rejection of submitted Late Breaking abstracts will be sent to the corresponding authors via email.
LATE BREAKING ABSTRACTS
The organizers invite Authors to submit their late breaking abstracts for consideration and inclusion in the “Late breaking abstract session”.
LATE BREAKING ABSTRACT SUBMISSION DEADLINE:
SEP 1, 2026
ABSTRACT EVALUATION:
SEP 15, 2026
SUBMISSION CRITERIA
Scientific data and results included in the late-breaking abstract submissions must be new and unpublished.
The following is a directive from the IADVL and applies to all international congresses being held in India.
Please note that according to the Indian Regulations Governing Procedural Dermatology Training and Congress Participation only Dermatologists and Plastic Surgeons (and their residents) are permitted to attend this years’ DASIL World Congress in India.
SELECTED ABSTRACTS PRESENTATION MODE
The Authors of selected abstracts will be invited to hold an oral presentation during the “Late breaking news session”.
E-posters cannot be submitted for the late-breaking news session.
The presenting author must register as a participant for the full congress.
ABSTRACT FORMALITIES
Incomplete abstracts or abstracts with formal errors will generally lead to the exclusion of abstracts!
Abstracts must be submitted as MS-Word or (editable) pdf document.
Abstracts must be submitted in English and must not exceed 300 words.
The abstract must clearly indicate the following (to be excluded from the word count):
-
Abstract title
-
Name(s) of author(s)
-
Affiliation of author(s)
-
Country of residence of author(s)
-
Current headshot for publication
The authors’ conclusion(s) should be clearly stated. General statements such as the significance of these findings will be considered unfavorably and will generally lead to the exclusion of abstracts.
Initials and abbreviations which are not in common use should be avoided unless they are essential.
Remember to check spelling and grammar carefully. Your electronically submitted abstract text will be reproduced as submitted.
SPEAKER DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
The DASIL Society requires that all presentations must be as bias free of commercials.
It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabled or research-associated commercial products should disclose this situation to session attendees.
ABSTRACT SUBMISSION
Authors may submit their abstract(s) via email to
batu_gezer(at)logi-vent.deOnly electronically submitted abstracts will be considered.
ABSTRACT EVALUATION
The DASIL Scientific Board will review all abstracts without knowledge of the author’s name. Acceptance or rejection of an abstract will be based on the average grade awarded by the review committee.
The abstract should be presented in a way that the contribution of the research to advance knowledge can be assessed.
The Scientific Board reserves the right to:
-
Select the abstracts relevant to the sessions
-
Decide on the final topic of the abstract
By submitting an abstract for the 14th DASIL World Congress, the author confirms that he/she has read and understood the terms & conditions and accepts them.
